Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial

Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-15T21:34:10.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-05-08T14:33:59.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.4%
    Check dated 2025-05-01T06:37:01.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-24T02:13:08.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of detailed information about various leukemia types and associated treatments, particularly focusing on the drug Revumenib and its clinical trial details. Additionally, the revision number has been updated to v2.15.0.
    Difference
    43%
    Check dated 2025-04-16T20:53:33.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 19, 2025.
    Difference
    0.5%
    Check dated 2025-04-09T16:00:06.000Z thumbnail image

Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.